[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2003/158179,2003,A1
[1]CurrentPatentAssignee:ABBVIEINC-US6933311,2005,B2
[2]CurrentPatentAssignee:ABBVIEINC-US2004/157849,2004,A1
24358-43-8 | 1-(3-Chlorophenyl)ethanamine | AA00C1UE | MFCD05215231
23600-77-3 | 4-Bromophenyl propionate | AA00C1YZ | MFCD08778224
2208-24-4 | 4,6-Difluorobenzimidazole | AA00C244 | MFCD03425145
23363-35-1 | 4'-demethylepipodophyllotoxin-9 beta-glucopyranoside | AA00C2AV | MFCD01725594
24269-96-3 | 5-[2-(5-Nitro-2-furanyl)ethenyl]-2-furancarboxylic Acid Methyl Ester | AA00C2ID | MFCD00099039
218136-59-5 | (E)-2,2-Diphenyl-5-(4-((pyridin-3-ylmethylene)amino)piperazin-1-yl)pentanenitrile | AA00C2O4 | MFCD11226148
251647-48-0 | N-Benzoyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-o-(2-methoxyethyl)adenosine | AA00C2UQ | MFCD14586330
219719-95-6 | (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione | AA00C311 | MFCD31563235
29118-61-4 | N-(1-Deoxy-D-fructose-1-yl)-L-proline | AA00C387 | MFCD28899048
267234-08-2 | [NPHE1]NOCICEPTIN(1-13)NH2 | AA00C3G3 | MFCD03093512